Stifel Financial Corp Ultragenyx Pharmaceutical Inc. Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

A detailed history of Stifel Financial Corp transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 20,961 shares of RARE stock, worth $938,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,961
Previous 21,827 3.97%
Holding current value
$938,004
Previous $897,000 29.77%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$40.21 - $59.36 $34,821 - $51,405
-866 Reduced 3.97%
20,961 $1.16 Million
Q2 2024

Aug 13, 2024
BUY
$37.42 - $51.61 $316,610 - $436,672
8,461 Added 63.3%
21,827 $897,000
Q1 2024

May 13, 2024
BUY
$43.02 - $53.69 $37,513 - $46,817
872 Added 6.98%
13,366 $624,000
Q4 2023

Feb 12, 2024
BUY
$31.73 - $49.19 $84,211 - $130,550
2,654 Added 26.97%
12,494 $597,000
Q3 2023

Nov 13, 2023
BUY
$34.92 - $46.66 $151,657 - $202,644
4,343 Added 79.01%
9,840 $350,000
Q2 2023

Aug 14, 2023
BUY
$37.35 - $52.15 $205,312 - $286,668
5,497 New
5,497 $253,000
Q2 2022

Aug 15, 2022
BUY
$45.8 - $85.4 $1,694 - $3,159
37 Added 0.96%
3,905 $233,000
Q1 2022

May 13, 2022
BUY
$62.2 - $84.4 $37,942 - $51,484
610 Added 18.72%
3,868 $281,000
Q4 2021

Feb 14, 2022
SELL
$73.71 - $87.86 $7,370 - $8,786
-100 Reduced 2.98%
3,258 $274,000
Q3 2021

Nov 15, 2021
BUY
$77.92 - $102.4 $25,791 - $33,894
331 Added 10.93%
3,358 $303,000
Q2 2021

Aug 13, 2021
SELL
$92.19 - $115.71 $54,299 - $68,153
-589 Reduced 16.29%
3,027 $289,000
Q1 2021

May 14, 2021
SELL
$106.9 - $167.73 $13,362 - $20,966
-125 Reduced 3.34%
3,616 $412,000
Q4 2020

Feb 12, 2021
BUY
$84.4 - $177.39 $59,080 - $124,172
700 Added 23.02%
3,741 $518,000
Q3 2020

Nov 16, 2020
SELL
$72.98 - $90.0 $14,158 - $17,460
-194 Reduced 6.0%
3,041 $250,000
Q2 2020

Aug 14, 2020
SELL
$46.91 - $78.22 $72,710 - $121,241
-1,550 Reduced 32.39%
3,235 $253,000
Q1 2020

May 14, 2020
BUY
$33.8 - $62.9 $161,733 - $300,976
4,785 New
4,785 $213,000
Q2 2019

Aug 14, 2019
SELL
$54.93 - $74.36 $622,192 - $842,275
-11,327 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$39.87 - $69.36 $451,607 - $785,640
11,327 New
11,327 $786,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.13B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email